HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Meta-analysis
Bibliometric analysis maps research trends and key contributors in immune checkpoint inhibitors for endometrial cancer
Mapping the Research Landscape of Immune Therapy for Endometrial Cancer
This systematic review uses a bibliometric analysis to map the landscape of immune checkpoint inhibitor research in endometrial cancer. The …
A large-scale analysis maps out how researchers worldwide are studying immune checkpoint inhibitors to treat endometrial cancer.
Frontiers
Jun 8, 2026
Allergy & Immunology
Sys. Review
Artificial intelligence as a mechanistic microscope and digital twin in colorectal cancer faces generalizability and regulatory validation limitations
Artificial intelligence acts as a digital microscope for colorectal cancer patients
This narrative review discusses the use of artificial intelligence as a mechanistic microscope and digital twin for patients with colorectal…
A review explores how artificial intelligence could help doctors see colorectal cancer better, though more testing is needed before patients…
Frontiers
Jun 7, 2026
Drug Pipeline
Sys. Review
Narrative review discusses Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis risks from various medications
A review explains which drugs may cause severe skin reactions like Stevens-Johnson Syndrome
This narrative review examines Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis associated with antibiotics, antiepileptics, allopuri…
This review looks at medications linked to rare but dangerous skin conditions. It helps doctors and patients understand the risks.
Frontiers
Jun 2, 2026
Pulmonology & Critical Care
Meta-analysis
Immune checkpoint inhibitors before lung cancer surgery show acceptable safety profile
Immunotherapy before lung cancer surgery is safe, study finds
This meta-analysis of patients with resectable non-small cell lung cancer found that neoadjuvant or perioperative immune checkpoint inhibito…
A new analysis of 2,691 patients shows that immunotherapy before lung cancer surgery is feasible, but comes with specific surgical challenge…
Jun 1, 2026
Allergy & Immunology
Meta-analysis
Immune checkpoint inhibitors appear safe in cancer patients with pre-existing sarcoidosis
Most cancer patients with sarcoidosis stay safe on immune checkpoint inhibitor therapy
A meta-analysis examined immune checkpoint inhibitor use in cancer patients with documented pre-existing sarcoidosis. Most patients showed n…
A look at 43 patients shows most do not have a flare when taking immune checkpoint inhibitors, though some do experience a flare.
Jun 1, 2026
Allergy & Immunology
Sys. Review
Review: Targeting mRNA Processing Enhances Immune Checkpoint Blockade in Cancer
New cancer treatments target RNA to boost immune system power
This review examines strategies targeting mRNA processing (alternative splicing, RNA modifications, RNA editing) combined with immune checkp…
Scientists found that combining RNA processing strategies with immune checkpoint blockade creates powerful synergistic effects for treating …
Frontiers
May 25, 2026
Oncology
Meta-analysis
Meta-analysis shows immune checkpoint inhibitor combinations improve survival and response rates in advanced cervical cancer patients with manageable safety profiles
ICI Combinations Improve Survival for Advanced Cervical Cancer
This systematic review analyzed 4,441 patients with advanced cervical cancer to evaluate immune checkpoint inhibitor combinations. Results i…
Combining immune checkpoint inhibitors with other treatments significantly improved survival and disease control for patients with advanced …
Frontiers
May 25, 2026
Oncology
Meta-analysis
Network meta-analysis suggests immune checkpoint inhibitor regimens improve survival in advanced gastric cancer compared to chemotherapy alone
New analysis suggests dual-target immune checkpoint inhibitors may improve survival for advanced gastric cancer patients
This network meta-analysis evaluated immune checkpoint inhibitor regimens versus chemotherapy for patients with advanced gastric cancer. The…
A large network meta-analysis suggests dual-target immune checkpoint inhibitors combined with chemotherapy may improve survival for advanced…
May 24, 2026
Allergy & Immunology
Sys. Review
Narrative review discusses colorectal cancer metastasis patterns with immune checkpoint inhibitors and targeted therapies
Liver metastasis linked to resistance in colorectal cancer treated with immune checkpoint inhibitors
This narrative review examines response patterns to immune checkpoint inhibitors, anti-angiogenic agents, and targeted therapies in colorect…
A review of colorectal cancer treatments suggests liver metastasis is linked to resistance against immune checkpoint inhibitors, while lung …
Frontiers
May 21, 2026
Oncology
Meta-analysis
Meta-analysis links emotional distress to worse outcomes in advanced lung cancer
Emotional distress linked to worse lung cancer survival
This systematic review and meta-analysis of 911 patients with advanced NSCLC found emotional distress was significantly associated with redu…
For people with advanced lung cancer, feeling emotionally distressed is tied to lower survival and worse treatment response, a new analysis …
Frontiers
May 21, 2026
Oncology
Meta-analysis
Systematic review of immune checkpoint inhibitors in cancer efficacy and safety
Immune Checkpoint Inhibitors Show Promise For Cancer Patients With High Tumor Burden
This systematic review synthesizes evidence from 15 randomized trials and cohort studies on immune checkpoint inhibitors in cancer. It finds…
A review of trials suggests immune checkpoint inhibitors work well for some cancer patients but carry risks like skin rashes and organ infla…
Frontiers
May 20, 2026
Oncology
Meta-analysis
Network meta-analysis compares therapies for liver metastatic uveal melanoma
Liver-directed therapy combined with ICIs leads for metastatic uveal melanoma survival
This systematic review and network meta-analysis synthesized evidence on therapeutic modalities for patients with liver metastatic uveal mel…
A network meta-analysis of 2,585 patients found liver-directed therapy combined with immune checkpoint inhibitors offered the best survival …
Frontiers
May 20, 2026